Vectors derived from simian immunodeficiency virus (SIV)

Biochimie

Volumn 84, Issue 11, 2002, Pages 1161-1171

  Nègre, Didier ^a   Cosset, François Loïc ^a  

^a University Lyon i   (France)

Author keywords

Bio safety; Gene therapy; Lentivirus vectors; Pseudotypes; RCR; SIV

Indexed keywords

LENTIVIRUS VECTOR; RETROVIRUS VECTOR; VIRUS GLYCOPROTEIN;

BIOSAFETY; CANCER CELL CULTURE; CONFERENCE PAPER; GENE DELIVERY SYSTEM; GENE THERAPY; GENE TRANSFER; GENETIC ORGANIZATION; GENETIC TRANSDUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIMATE; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; SAFETY; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSGENE; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS GENOME; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; GENE TRANSFER TECHNIQUES; GENETIC TECHNIQUES; GENETIC VECTORS; LEUKEMIA VIRUS, MURINE; MICE; SIMIAN IMMUNODEFICIENCY VIRUS;

LENTIVIRUS; MURINAE; MURINE LEUKEMIA VIRUS; PRIMATES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0036881616     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(02)00036-6     Document Type: Conference Paper

References (76)

1. D. Nègre, G. Duisit, P.E. Mangeot, P. Moullier, J.L. Darlix, F.L. Cosset, Lentiviral vectors derived from simian immunodeficiency virus (SIV), in: D. Trono (Ed.), Current Topics in Microbiology and Immunology, vol. 261, 2002, pp. 53-74.
2. L. Naldini, U. Blömer, P. Gallay, D. Ory, R. Mulligan, F.H. Gage, I.M. Verma, D. Trono, In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector, Science 272 (1996) 263-267.
3. D. Nègre, P. Mangeot, G. Duisit, S. Blanchard, P. Vidalain, P. Leissner, A. Winter, C. Rabourdin-Combe, M. Mehtali, P. Moullier, J.L. Darlix, F.L. Cosset, Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIV mac251) that efficiently transduce mature human dendritic cells, Gene Ther. 7 (2000) 1613-1623.
4. J. Clements, M. Zink, Molecular biology and pathogenesis of animal lentivirus infections, Clin. Microbiol. Rev. 9 (1996) 100-117.
5. M. Gardner, M. Endres, P. Barry, The simian retroviruses SIV and SRV, in: J. Levy (Ed.), The Retroviridae, vol. 3, Plenum Press, New York, 1993, pp. 133-276.
6. P. Bieniasz, T. Grdina, H. Bogerd, B. Cullen, Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes, J. Virol. 73 (1999) 5777-5786.
7. R. Schneider, M. Campbell, G. Nasioulas, B.K. Felber, G.N. Pavlakis, Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation, J. Virol. 71 (1997) 4892-4903.
8. R. Wagner, M. Graf, K. Bieler, H. Wolf, T. Grunwald, P. Floley, K. Uberla, Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: Implications for the safety of lentiviral vectors, Hum. Gene Ther. 11 (2000) 2403-2413.
9. M. Emerman, M.H. Malim, HIV-1 regulatory/accessory genes: Keys to unraveling viral and host cell biology, Science 280 (1998) 1880-1884.
10. C. Depienne, P. Roques, C. Creminon, L. Fritsch, R. Casseron, D. Dormont, C. Dargemont, S. Benichou, Cellular distribution and karyophilic properties of matrix, integrase, and vpr proteins from the human and simian immunodeficiency viruses, Exp. Cell Res. 260 (2000) 387-395.
11. S. Mahalingam, B.V. Tine, M. Santiago, F. Gao, G. Shaw, B. Hahn, Functional analysis of the simian immunodeficiency virus vpx protein: Identification of packaging determinants and a novel nuclear targeting domain, J. Virol. 75 (2001) 362-374.
12. P. Luciw, N. Leung, Mechanisms of retrovirus replication, in: J. Levy (Ed.), The Retroviridae, vol. 1, Plenum Press, New York, 1993, pp. 159-298.
13. P. Ilyinskii, R. Desrosiers, Identification of a sequence element immediately upstream of the polypurine tract that is essential for replication of simian immunodeficiency virus, EMBO J. 17 (1998) 3766-3774.
14. M.I. Bukrinsky, N. Sharova, M.P. Dempsey, T.L. Stanwick, A.G.T.L. Stanwick, S. Haggerty, M. Stevenson, Active nuclear import of human immunodeficiency virus type 1 preintegration complexes, Proc. Natl. Acad. Sci. USA 89 (1992) 6580-6584.
15. M.I. Bukrinsky, S. Haggerty, M.P. Dempsey, N. Sharova, A. Adzhubel, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman, M. Stevenson, A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells, Nature 365 (1993) 666-669.
16. P. Gallay, T. Hope, D. Chin, D. Trono, HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway, Proc. Natl. Acad. Sci. 94 (1997) 9825-9830.
17. N.K. Heinzinger, M.I. Bukrinsky, S.A. Haggerty, A.M. Ragland, V. Kewalramani, M.A. Lee, H.E. Gendelman, L. Ratner, M. Stevenson, M. Emerman, The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells, Proc. Natl. Acad. Sci. 91 (1994) 7311-7315.
18. M.I. Bukrinsky, O.K. Haffar, HIV-1 nuclear import: In search of a leader, Front Biosci. 4 (1999) D772-D781.
19. V. Zennou, C. Petit, D. Guetard, U. Nerhbass, L. Montagnier, P. Charneau, HIV-1 genome nuclear import is mediated by a central DNA flap, Cell 101 (2000) 173-185.
20. A. Follenzi, L. Ailles, S. Bakovic, M. Geuna, L. Naldini, Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences, Nat. Genet. 25 (2000) 217-222.
21. Y. Guan, J. Whitney, K. Diallo, M. Wainberg, Leader sequences downstream of the primer binding site are important for efficient replication of simian immunodeficiency virus, J. Virol. 74 (2000) 8854-8860.
22. A. Das, B. Klaver, B. Klasens, Jv. Wamelv, B. Berkhout, A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication, J. Virol. 71 (1997) 2346-2356.
23. N. Dorman, A. Lever, Comparison of viral genomic RNA sorting mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and moloney murine leukemia virus, J. Virol. 74 (2000) 11413-11417.
24. J.F. Kaye, A.M. Lever, Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: A possible role for the p2 domain of Gag in RNA encapsidation, J. Virol. 72 (1998) 5877-5885.
25. L. Giavedoni, T. Yilma, Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon, J. Virol. 70 (1996) 2247-2251.
26. R. Ruprecht, Live attenuated AIDS viruses as vaccines: Promise or peril? Immunol. Rev. 170 (1999) 135-149.
27. P.E. Mangeot, D. Nègre, B. Dubois, A.J. Winter, P. Leissner, M. Methali, D. Kaiserlian, F.L. Cosset, J.L. Darlix, Development of minimal lentiviral vectors derived from simian immunodeficiency virus (SIV mac251) and their use for the gene transfer in human dendritic cells, J. Virol. 74 (2000) 8307-8315.
28. T. Schnell, P. Foley, W. Wirth, J. Munch, K. Uberla, Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus, Hum. Gene Ther. 11 (2000) 439-447.
29. T. Nakajima, K. Nakamaru, E. Ido, K. Terao, M. Hayami, M. Hasegawa, Development of novel simian immunodeficiency virus vectors carrying a dual gene expression system, Hum. Gene Ther. 11 (2000) 1863-1874.
30. J. Stitz, M.D. Muhlebach, U. Blomer, M. Scherr, M. Selbert, P. Wehner, S. Steidl, I. Schmitt, R. Konig, M. Schweizer, K.A. Cichutek, A novel lentivirus vector derived from apathogenic simian immunodeficiency virus, Virology 291 (2001) 191-197.
31. P.E. Mangeot, K. Duperrier, D. Negre, B. Boson, D. Rigal, F.L. Cosset, J.L. Darlix, High levels of transduction of human dendritic cells with optimized SIV vectors, Mol. Ther. 5 (2002) 283-290.
32. M. Belshan, G.S. Park, P. Bilodeau, C.M. Stoltzfus, S. Carpenter, Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs, Mol. Cell Biol. 20 (2000) 3550-3557.
33. R. Zufferey, J.E. Donello, D. Trono, T.J. Hope, Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors, J. Virol. 73 (1999) 2886-2892.
34. V. Sandrin, B. Boson, P. Salmon, W. Gay, D. Nègre, R.L. Grand, D. Trono, F.L. Cosset, Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and non-human primates, Blood 100 (2002) 823-832.
35. G.P. Kobinger, D.J. Weiner, Q.C. Yu, J.M. Wilson, Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo, Nat. Biotechnol. 19 (2001) 225-230.
36. J. Gatlin, M.W. Melkus, A. Padgett, P.F. Kelly, J.V. Garcia, Engraftment of NOD/SCID mice with human CD34+ cells transduced by concentrated oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein, J. Virol. 75 (2001) 9995-9999.
37. M. Goerner, P.A. Horn, L. Peterson, P. Kurre, R. Storb, J.E. Rasko, H.P. Kiem, Sustained multilineage gene persistence and expression in dogs transplanted with CD34(+) marrow cells transduced by RD114-pseudotype oncoretrovirus vectors, Blood 98 (2001) 2065-2070.
38. P. Kelly, J. Vandergriff, A. Nathwani, A. Nienhuis, E. Vanin, Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein, Blood 96 (2000) 1206-1214.
39. C.D. Porter, M.K.L. Collins, C.S. Tailor, M.H. Parker, F.L. Cosset, R.A. Weiss, Y. Takeuchi, Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors, Hum. Gene Ther. 7 (1996) 913-919.
40. G. Duisit, H. Conrath, S. Saleun, S. Folliot, N. Provost, F.L. Cosset, V. Sandrin, P. Moullier, F. Rolling, Five recombinant SIV pseudotypes lead to exclusive transduction of retinal pigmented epithelium in rat, Mol. Ther. (2002) (in press).
41. S. Kuate, R. Wagner, K. Uberla, Development and characterization of a minimal inducible packaging cell line for simian immunodeficiency virus-based lentiviral vectors, J. Gene Med. 4 (2002) 347-355.
42. B. Chackerian, N.L. Haigwood, J. Overbaugh, Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates, Virology 213 (1995) 386-394.
43. D.E. Ott, Cellular proteins in HIV virions, Rev. Med. Virol. 7 (1997) 167-180.
44. R. Swanstrom, J.W. Wills, Synthesis, assembly, and processing of viral proteins, in: J.M. Coffins, S.H. Hughes, H.E. Varmus (Eds.), Retroviruses, Cold Spring Harbor Laboratory Press, New York, USA, 1997, pp. 263-334.
45. I. Christodoulopoulos, P. Cannon, Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors, J. Virol. 75 (2001) 4129-4138.
46. N. Desmaris, A. Bosch, C. Salaun, C. Petit, M.C. Prevost, N. Tordo, P. Perrin, O. Schwartz, H. DeRocquigny, J.M. Heard, Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins, Mol. Ther. 4 (2001) 149-156.
47. B.C. Lewis, N. Chinnasamy, R.A. Morgan, H.E. Varmus, Development of an avian leukosis-sarcoma virus subgroup a pseudotyped lentiviral vector, J. Virol. 75 (2001) 9339-9344.
48. H. Mochizuki, J.P. Schwartz, K. Tanaka, R.O. Brady, J. Reiser, High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells, J. Virol. 72 (1998) 8873-8883.
49. P. Salmon, D. Nègre, D. Trono, F.L. Cosset, A chimeric GALV-derived envelope glycoprotein harboring the cytoplasmic tail of MLV envelope efficiently pseudotypes HIV-1 vectors, J. Gen. Med. 2 (Suppl) (2000) 23.
50. J. Stitz, C. Buchholz, M. Engelstadter, W. Uckert, U. Bloemer, I. Schmitt, K. Cichutek, Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1, Virology 273 (2000) 16-20.
51. A. Marandin, A. Dubart, F. Pflumio, F.L. Cosset, V. Cordette, S. Chapel-Fernandes, L. Coulombel, W. Vainchenker, F. Louache, Retroviral-mediated gene transfer into human CD34+/38-primitive cells capable of reconstituting long-term cultures in vitro and in nonobese diabetic-severe combined immunodeficiency mice in vivo, Hum. Gene Ther. 9 (1998) 1497-1511.
52. M. Movassagh, C. Desmyter, C. Baillou, S. Chapel-Fernades, M. Guigon, D. Klatzmann, F.M. Lemoine, High-level gene transfer to cord blood progenitors using gibbon ape leukemia virus pseudotyped retroviral vectors and an improved clinically applicable protocol, Hum. Gene Ther. 9 (1998) 225-234.
53. K.W. Peng, L. Pham, H. Ye, R. Zufferey, D. Trono, F.L. Cosset, S.J. Russell, Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors, Gene Ther. 8 (2001) 1456-1463.
54. J.C. Burns, T. Friedmann, W. Driever, M. Burrascano, J.K. Yee, Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells, Proc. Natl. Acad. Sci. USA 90 (1993) 8033-8037.
55. L. Seganti, F. Superti, C. Girmenia, L. Melucci, N. Orsi, Study of receptors for vesicular stomatitis virus in vertebrate and invertebrate cells, Microbiologica 9 (1986) 259-267.
56. N.J. DePolo, J.D. Reed, P.L. Sheridan, K. Townsend, S.L. Sauter, D.J. Jolly, T.W. Dubensky, VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum, Mol. Ther. 2 (2002) 218-222.
57. F.L. Cosset, Y. Takeuchi, J. Battini, R. Weiss, M. Collins, High titer packaging cells producing recombinant retroviruses resistant to human serum, J. Virol. 69 (1995) 7430-7436.
58. T. Hatziioannou, E. Delahaye, F. Martin, S.J. Russell, F.L. Cosset, Retroviral display of functional binding domains fused to the amino-terminus of influenza haemagglutinin, Hum. Gene Ther. 10 (1999) 1533-1544.
59. V. Sandrin, B. Boson, F.L. Cosset, Insertion of lentiviral protease substrates in the cytoplasmic tail of the feline endogenous virus RD114 glycoprotein enhances viral incorporation and infectivity of pseudotyped lentiviral vectors, 2001 (in preparation).
60. F.L. Cosset, F.J. Morling, Y. Takeuchi, R.A. Weiss, M.K.L. Collins, S.J. Russell, Retroviral retargeting by envelopes expressing an N-terminal binding domain, J. Virol. 69 (1995) 6314-6322.
61. A. Fielding, S. Chapel-Fernandes, M. Chadwick, F. Bullough, F.L. Cosset, S. Russell, A hyperfusogenic Gibbon ape leukemia virus envelope glycoprotein: Targeting of a cytotoxic gene by ligand display, Hum. Gene Ther. 11 (2000) 817-826.
62. D. Lavillette, S.J. Russell, F.L. Cossett, Retargeting gene delivery by surface-engineered retroviral vector particles, Curr. Opin. Biotechnol. 12 (2001) 461-466.
63. S.J. Russell, F.L. Cosset, Modifying the host range properties of retroviral vectors, J. Gene Med. 1 (1999) 300-311.
64. R. Desrosiers, J. Lifson, J. Gibbs, S. Czajak, A. Howe, L. Arthur, R. Johnson, Identification of highly attenuated mutants of simian immunodeficiency virus, J. Virol. 72 (1998) 1431-1437.
65. W.S. Hu, H.M. Temin, Retroviral recombination and reverse transcription, Science 250 (1990) 1227.
66. S. Reiprich, B. Gundlach, B. Fleckenstein, K. Uberla, Replication-competent chimeric lenti-oncovirus with expanded host cell tropism, J. Virol. 71 (1997) 3328-3331.
67. A. Girod, F.L. Cosset, G. Verdier, C. Ronfort, Analysis of ALV-based packaging cell lines for production of contaminant defective viruses, Virology 209 (1995) 671-675.
68. A. Girod, A. Drynda, F.L. Cosset, G. Verdier, C. Ronfort, Homologous and non-homologous retroviral recombination are both involved in the transfer by infectious particles of defective (ALV)-derived transcomplementing genomes, J. Virol. 70 (1996) 5651-5657.
69. H. Chong, W. Starkey, R. Vile, A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences, J. Virol. 72 (1998) 2663-2670.
70. F.L. Cosset, A. Girod, F. Flamant, A. Drynda, C. Ronfort, S. Valsesia, R.M. Molina, C. Faure, V.M. Nigon, G. Verdier, Use of helper cells with two host ranges to generate high-titer retroviral vectors, Virology 193 (1993) 385-395.
71. C. Ronfort, A. Girod, F.L. Cosset, C. Legras, V.M. Nigon, Y. Chebloune, G. Verdier, Defective retroviral endogenous RNA is efficiently transmitted by infectious particles produced on an avian retroviral vector packaging cell line, Virology 207 (1995) 271-275.
72. C. Patience, Y. Takeuchi, F.L. Cosset, R. Weiss, Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells, J. Virol. 72 (1998) 2671-2676.
73. M.K.L. Collins, R.A. Weiss, Y. Takeuchi, F.L. Cosset, Expression systems, PCT/GB96/02061, WO 97/08330, 1996.
74. J.D. Boeke, J.P. Stoye, Retrotransposons, endogenous retroviruses, and the evolution of retroelements, in: J.M. Coffin, S.H. Hughes, H.E. Varmus (Eds.), Retroviruses, Cold Spring Harbor Laboratory Press, New York, USA, 1997, pp 343-435.
75. B. Hahn, G. Shaw, K.D. Cock, P. Sharp, AIDS as a zoonosis: Scientific and public health implications, Science 287 (2000) 607-614.
76. H. McClure, F. Novembre, Simian immunodeficiency virus variants: Threat of new lentiviruses, Am. J. Med. Sci. 311 (1996) 30-33.